1. |
Gomma AI, Khan SA, Toledano MB, et al. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis [J]. World J Gastroenterol, 2008; 14(27): 43004308.
|
2. |
But DY, Lai CL, Yuen MF. Natural history of hepatitisrelated hepatocellular carcinoma [J]. World J Gastroenterol, 2008; 14(11): 16521656.
|
3. |
Hanna RE, Aguirre DA, Kased N, et al. Cirrhosisassociated hepatocellular nodules: correlation of histopathologic and MR imaging features [J]. Radiographics, 2008; 28(3): 747769.
|
4. |
Krinsky G. Terminology of hepatocellular nodules in cirrhosis: plea for consistency [J]. Radiology, 2002; 224(3): 638.
|
5. |
Nascimento C, Bottino A, Nogueira C, et al. Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers [J]. Diagn Pathol, 2007; 2: 51.
|
6. |
吴苾, 宋 彬. 肝硬变结节性病变的影像学和相关病理学表现 [J]. 中国普外基础与临床杂志, 2003; 10(3): 288294.
|
7. |
BaSsalamah A, Schima W, Schmook MT, et al. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liverspecific MR contrast agents [J]. AJR Am J Roentgenol, 2002; 179(6): 14471456.
|
8. |
Lim JH, Choi D, Cho SK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides enhanced MR imaging: importance of Kupffer cell number [J]. Radiology, 2001; 220(3): 669676.
|
9. |
Hussain SM, Zondervan PE, IJzermans JN, et al. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation [J]. Radiographics, 2002; 22(5): 10231039.
|
10. |
孟令平, 万凯明, 俞忠辉, 等. MRI 鉴别诊断肝硬化退变结节与小肝癌 [J]. 中国医学影像技术, 2005; 21(6): 923926.
|
11. |
Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrastenhanced MRI of the liver: properties, clinical development and applications [J]. Eur Radiol, 2004; 14(4): 559578.
|
12. |
Lupescu IG, Capsa RA, Gheorghe L, et al. Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules [J]. J Gastrointestin Liver Dis, 2008; 17(3): 341346.
|
13. |
Gandhi SN, Brown MA, Wong JG. MR contrast agents for liver imaging: what, when, how [J]. Radiographics, 2006; 26(6): 16211636.
|
14. |
Bhartia B, Ward J, Guthrie JA, et al. Hepatocellular carcinoma in cirrhotic livers: doublecontrast thinsection MR imaging with pathologic correlation of explanted tissue [J]. AJR Am J Roentgenol, 2003; 180(3): 577584.
|
15. |
Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusionweighted singleshot echoplanar MR imaging technique [J]. Eur Radiol, 2008; 18(3): 477485.
|
16. |
Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two singleshot echoplanar MR imaging sequences: prospective study in 66 patients [J]. Radiology, 2003; 226(1): 7178.
|
17. |
Demir OI, Obuz F, Saol O, et al. Contribution of diffusionweighted MRI to the differential diagnosis of hepatic masses [J]. Diagn Interv Radiol, 2007; 13(2): 8186.
|
18. |
杨洋, 宋彬, 吴苾. 慢性病毒性肝炎组织病理学分级和磁共振弥散成像的对照研究 [J]. 中国普外基础与临床杂志, 2006; 13(4): 469473.
|
19. |
Xu H, Xie JX, Li X, et al. Perfusionweighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model [J]. J Magn Reson Imaging, 2008; 27(1): 102109.
|
20. |
Pandharipande PV, Krinsky GA, Rusinek H, et al. Perfusion imaging of the liver: current challenges and future goals [J]. Radiology, 2005; 234(3): 661673.
|
21. |
刘于宝, 梁长虹, 张忠林, 等. 31P MR波谱成像在肝脏的初步临床应用研究 [J]. 实用放射学杂志, 2006; 22(4): 417420.
|
22. |
Corbin IR, Buist R, Peeling J, et al. Hepatic 31PMRS in rat models of chronic liver disease: assessing the extent and progression of disease [J]. Gut, 2003; 52(7): 10461053.
|
23. |
Foley LM. Towner RA. Painter DM. In vivo imageguided 1Hmagnetic resonance spectroscopy of the serial development of hepatocarcinogenesis in an experimental animal model [J]. Biochim Biophys Acta, 2001; 1526(3): 230236.
|